Several Prostate Cancer Drug Candidates Heading Into Home Stretch
Executive Summary
In the next year or so, the race to develop new drug therapies for aggressive end-stage prostate cancer could heat up considerably, with several late-stage therapies due to report data in 2009 and early 2010
You may also be interested in...
Medivation Gets $110M Upfront From Astellas In Prostate Cancer Collaboration
As in its Dimebon collaboration with Pfizer, the biotech gets significant U.S. profit-sharing along with an option for co-promotion.
Medivation Gets $110M Upfront From Astellas In Prostate Cancer Collaboration
As in its Dimebon collaboration with Pfizer, the biotech gets significant U.S. profit-sharing along with an option for co-promotion.
Circulating Tumor Cell Detection A Technology To Watch In 2009 – Cleveland Clinic
Technology offers more rapid feedback on metastatic cancer progression than imaging or tumor-localized biomarker tests, clinic says.